Biomarin Pharmaceutical (BMRN) Cash from Investing Activities Growth (1y) (2010 - 2026)
Biomarin Pharmaceutical (BMRN) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.52 Bn |
8.29 Bn |
571.21 Mn |
2,669.33% |
| Date | Value |
|---|
| Mar 31, 2026 |
2,669.33% |
| Dec 31, 2025 |
-155.56% |
| Sep 30, 2025 |
-1,948.42% |
| Jun 30, 2025 |
-113.92% |
| Mar 31, 2025 |
-98.36% |
| Dec 31, 2024 |
217.61% |
| Sep 30, 2024 |
64.72% |
| Jun 30, 2024 |
206.40% |
| Mar 31, 2024 |
52.57% |
| Dec 31, 2023 |
-18.74% |
| Sep 30, 2023 |
-95.71% |
| Jun 30, 2023 |
199.43% |
| Mar 31, 2023 |
-134.19% |
| Dec 31, 2022 |
1.28% |
| Sep 30, 2022 |
80.47% |
| Jun 30, 2022 |
75.30% |
| Mar 31, 2022 |
224.01% |
| Dec 31, 2021 |
-602.59% |
| Sep 30, 2021 |
-212.32% |
| Jun 30, 2021 |
51.66% |
